Delta Capital Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.8M Buy
17,940
+130
+0.7% +$25.5K 1.75% 17
2026
Q1
$3.49M Buy
17,810
+100
+0.6% +$19.4K 1.92% 15
2025
Q4
$3.07M Sell
17,710
-2,600
-13% -$473K 1.73% 23
2025
Q3
$3.87M Sell
20,310
-35
-0.2% -$6.21K 2% 15
2025
Q2
$3.65M Hold
20,345
2.04% 17
2025
Q1
$3.44M Sell
20,345
-440
-2% -$72.3K 2% 16
2024
Q4
$3.14M Sell
20,785
-40
-0.2% -$6.22K 1.79% 22
2024
Q3
$3.23M Hold
20,825
1.86% 20
2024
Q2
$2.85M Sell
20,825
-30
-0.1% -$4.11K 1.72% 20
2024
Q1
$2.78M Hold
20,855
1.84% 24
2023
Q4
$2.88M Sell
20,855
-40
-0.2% -$5.26K 2.01% 19
2023
Q3
$2.55M Sell
20,895
-520
-2% -$69.3K 1.91% 24
2023
Q2
$3.01M Sell
21,415
-220
-1% -$30.3K 2.07% 18
2023
Q1
$3.06M Sell
21,635
-90
-0.4% -$12.9K 2.15% 16
2022
Q4
$3.4M Buy
21,725
+40
+0.2% +$5.75K 2.48% 10
2022
Q3
$2.66M Hold
21,685
2.17% 14
2022
Q2
$2.88M Sell
21,685
-20
-0.1% -$2.73K 2.17% 13
2022
Q1
$2.97M Sell
21,705
-2,150
-9% -$300K 1.98% 23
2021
Q4
$4.13M Sell
23,855
-75
-0.3% -$11.4K 2.31% 14
2021
Q3
$3.48M Sell
23,930
-10
-0% -$1.46K 2.16% 15
2021
Q2
$3.16M Sell
23,940
-190
-0.8% -$24.9K 1.96% 27
2021
Q1
$3.1M Buy
+24,130
New +$2.97M 1.98% 24

Other funds holding DGX

Delta Capital Management's DGX Position: Q2 2026 in Review

Delta Capital Management increased its Quest Diagnostics (DGX) stake by 0.73% in Q2 2026, buying an estimated $25.5K and bringing the position to 17,940 shares worth $3.8M. The position accounts for 1.75% of the portfolio, ranked #17.

Delta Capital Management first reported a position in DGX in Q1 2021 and has held it in 22 quarters since. The position peaked at $4.13M in Q4 2021. 287 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Delta Capital Management held 17,940 shares of Quest Diagnostics worth $3.8M as of Q2 2026.
  • Delta Capital Management bought 130 Quest Diagnostics shares in Q2 2026, an estimated $25.5K.
  • Quest Diagnostics made up 1.75% of Delta Capital Management's portfolio in Q2 2026, its #17 holding.
  • Delta Capital Management first reported a position in Quest Diagnostics in Q1 2021 and has held it in 22 quarters since.
  • Delta Capital Management's Quest Diagnostics position peaked at $4.13M in Q4 2021.
  • 287 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Delta Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.